Prescribing information for Metalyse 25mg
IMPORTANT: Please be advised, that the Summary of Product Characteristics (SmPC) for Metalyse® provided here is the English version as approved by the EMA for countries in the European Union. Always refer to the current prescribing information as approved in your country.
Open link below and scroll to page 15 for details on Metalyse 5000 units (25 mg) powder for solution for injection, for use in adults for the thrombolytic treatment of acute ischaemic stroke (AIS) within 4.5 hours from last known well and after exclusion of intracranial haemorrhage.
